From Medscape Ophthalmology

Medscape Medical News from the:

Association for Research in Vision and Ophthalmology (ARVO) 2013 Annual Meeting

May 05 - 09, 2013; Seattle, Washington

This coverage is not sanctioned by, nor a part of, the Association for Research in Vision and Ophthalmology.

Conference News

ARVO iPad Vision Test Big Hit With Macular Degeneration Patients
Medscape Medical News, May 31, 2013
ARVO Predictors of Rapid Glaucoma Progression Identified
Medscape Medical News, May 30, 2013
ARVO App Expands Screening for Diabetic Retinopathy
Medscape Medical News, May 29, 2013
ARVO Patients With Macular Degeneration at Increased Death Risk
Medscape Medical News, May 24, 2013
ARVO Antihypertensives Lower Macular Degeneration Risk
Medscape Medical News, May 24, 2013
ARVO Bevacizumab Cheaper Than Ranibizumab for Macular Degeneration
Medscape Medical News, May 23, 2013
ARVO Visual Gains With Bevacizumab at 2 Years, New Safety Signal
Medscape Medical News, May 15, 2013
ARVO Predictors of Diabetic Macular Edema Identified
Medscape Medical News, May 14, 2013
ARVO Bevacizumab, Ranibizumab Comparable for Macular Degeneration
Medscape Medical News, May 9, 2013
ARVO Antioxidants, Omega-3 Fail to Halt Macular Degeneration
Medscape Medical News, May 7, 2013

Medscape Ophthalmology© WebMD, LLC

Expert Commentary

ARVO 2013 Wrap-up: Noteworthy Retinal News
Roger F. Steinert, MD;
Baruch D. Kuppermann, MD, PhD

Previous Coverage

ARVO 2012 Annual Meeting

ARVO 2011 Annual Meeting

ARVO 2010 Annual Meeting